Plain-English translation of NCT07492979 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer pacing method—called conduction system pacing—works better than the standard approach for treating heart failure. In this study, doctors will randomly assign patients to receive either the newer method or the traditional method of pacing the heart using an implanted device. The goal is to find out which approach better protects patients from death and heart failure-related hospitalizations.
Heart failure patients with irregular heartbeats often benefit from a special pacing device, but doctors want to know if a newer technique for placing and using these devices could give better results than the method currently used in standard care.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have a device implanted during a procedure, and the surgeon will randomly choose whether to use the newer pacing method or the standard method. You and most of the study team will not know which method was used. You will then attend regular follow-up visits where doctors will monitor your heart health, check how well the device is working, and track any hospitalizations or health events over the study period.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Denmark
Finland
Norway
Sweden